You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Claims for Patent: 10,548,909

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,548,909

Title:	Co-crystals of tramadol and coxibs
Abstract:	The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain.
Inventor(s):	Plata Salaman; Carlos Ramon (Barcelona, ES), Tesson; Nicolas (L'Hospitalet de Llobregat, ES)
Assignee:	ESTEVE PHARMACEUTICALS, S.A. (Barcelona, ES)
Application Number:	16/275,437
Patent Claims:	1. A method of treatment of severe to moderate pain comprising administering to a patient in need thereof an effective amount of a co-crystal comprising (rac)-tramadol.HCl and celecoxib in a molecular ratio of 1:1, characterized in that it shows a Powder X-Ray Diffraction pattern with peaks [2.theta.] at 14.1, 16.8, 19.0 and 22.7[.degree.], with the 2.theta. values being obtained using copper radiation (CuK.alpha.1 1.54060 .ANG.). 2. The method of treatment of severe to moderate pain of claim 1, characterized in that the co-crystal shows additional peaks [2.theta.] at 7.1, 19.9 and 20.5[.degree.]. 3. The method of treatment of severe to moderate pain of claim 2, characterized in that the co-crystal shows additional peaks [2.theta.] at 13.6, 13.9, 17.5, 18.0, 19.5, 21.2, 21.3, 21.8, 22.6, 23.6, 24.1, 24.4 and 26.1[.degree.]. 4. A method of treatment of mild pain comprising administering to a patient in need thereof an effective amount of a co-crystal comprising (rac)-tramadol.HCl and celecoxib in a molecular ratio of 1:1, characterized in that it shows a Powder X-Ray Diffraction pattern with peaks [2.theta.] at 14.1, 16.8, 19.0 and 22.7[.degree.], with the 2.theta. values being obtained using copper radiation (CuK.alpha.1 1.54060 .ANG.). 5. The method of treatment of mild pain of claim 4, characterized in that the co-crystal shows additional peaks [2.theta.] at 7.1, 19.9 and 20.5[.degree.]. 6. The method of treatment of mild pain of claim 5, characterized in that the co-crystal shows additional peaks [2.theta.] at 13.6, 13.9, 17.5, 18.0, 19.5, 21.2, 21.3, 21.8, 22.6, 23.6, 24.1, 24.4 and 26.1[.degree.].

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.